Ipsen (FR:IPN) has released an update.
Ipsen, a global biopharmaceutical group, has been awarded the prestigious Shingo Prize for operational excellence at its Dublin production site, marking the company’s second receipt of the award following a previous win for its Signes site in France in 2020. The Shingo Prize recognizes exceptional commitment to operational principles by all staff members, reflecting Ipsen’s continuous improvement culture and dedication to maintaining a high level of production quality. This achievement highlights Ipsen’s operational achievements and their ongoing effort to avoid medicine shortages by maintaining excellent production standards.
For further insights into FR:IPN stock, check out TipRanks’ Stock Analysis page.
